Read the Latest News

Drawing on current research and clinical expertise, these articles address emerging trends, treatment considerations, and the complexities of care across the reproductive lifespan.

A small phase 2a trial of GH001, an investigational psychedelic compound, found a rapid reduction in postpartum depression symptoms. Larger studies are needed to assess safety and durability.
Perinatal OCD is common but often missed by depression-only screens. Adding perinatal-specific anxiety and OCD tools can improve detection and guide targeted treatment.
Please join us in welcoming our NP Masterclass Fall 2026 cohort!
Many women taking stimulants question whether it is safe to take these medications while breastfeeding.  

BLOG

Go to Top